The Evolution of Geriatric Oncology and Geriatric Assessment over the Past Decade

Darryl Outlaw; Maya Abdallah; Luiz A. Gil-Jr; Smith Giri; Tina Hsu; Jessica L. Krok-Schoen; Gabor Liposits; Tânia Madureira; Joana Marinho; Ishwaria M. Subbiah; Gina Tuch; Grant R. Williams

doi:10.1016/j.semradonc.2021.11.002

The Evolution of Geriatric Oncology and Geriatric Assessment over the Past Decade

Darryl Outlaw
, Maya Abdallah
, Luiz A. Gil-Jr
, Smith Giri
, Tina Hsu
, Jessica L. Krok-Schoen
, Gabor Liposits
, Tânia Madureira
, Joana Marinho
, Ishwaria M. Subbiah
, Gina Tuch
, Grant R. Williams^*

^*Kontaktforfatter

KI, OUH, Forskningsenhed for Onkologi (Odense)

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Abstract

Cancer is predominantly a disease of aging, and older adults represent the majority of cancer diagnoses and deaths. Older adults with cancer differ significantly from younger patients, leading to important distinctions in cancer treatment planning and decision-making. As a consequence, the field of geriatric oncology has blossomed and evolved over recent decades, as the need to bring personalized cancer care to older adults has been increasingly recognized and a focus of study. The geriatric assessment (GA) has become the cornerstone of geriatric oncology research, and the past year has yielded promising results regarding the implementation of GA into routine cancer treatment decisions and outcomes for older adults. In this article, we provide an overview of the field of geriatric oncology and highlight recent breakthroughs with the use of GA in cancer care. Further work is needed to continue to provide personalized, evidence-based care for each older adult with cancer.

Originalsprog	Engelsk
Tidsskrift	Seminars in Radiation Oncology
Vol/bind	32
Udgave nummer	2
Sider (fra-til)	98-108
ISSN	1053-4296
DOI	https://doi.org/10.1016/j.semradonc.2021.11.002
Status	Udgivet - apr. 2022

Bibliografisk note

Funding Information:
Supported in part by the National Cancer Institute of the National Institutes of Health (K08CA234225). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Finansiering

Supported in part by the National Cancer Institute of the National Institutes of Health (K08CA234225). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Dokumenter og links

10.1016/j.semradonc.2021.11.002

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943834

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

@article{aa2f800d0e3e42418636a64feb55f9f4,

title = "The Evolution of Geriatric Oncology and Geriatric Assessment over the Past Decade",

abstract = "Cancer is predominantly a disease of aging, and older adults represent the majority of cancer diagnoses and deaths. Older adults with cancer differ significantly from younger patients, leading to important distinctions in cancer treatment planning and decision-making. As a consequence, the field of geriatric oncology has blossomed and evolved over recent decades, as the need to bring personalized cancer care to older adults has been increasingly recognized and a focus of study. The geriatric assessment (GA) has become the cornerstone of geriatric oncology research, and the past year has yielded promising results regarding the implementation of GA into routine cancer treatment decisions and outcomes for older adults. In this article, we provide an overview of the field of geriatric oncology and highlight recent breakthroughs with the use of GA in cancer care. Further work is needed to continue to provide personalized, evidence-based care for each older adult with cancer.",

author = "Darryl Outlaw and Maya Abdallah and Gil-Jr, \{Luiz A.\} and Smith Giri and Tina Hsu and Krok-Schoen, \{Jessica L.\} and Gabor Liposits and T{\^a}nia Madureira and Joana Marinho and Subbiah, \{Ishwaria M.\} and Gina Tuch and Williams, \{Grant R.\}",

note = "Funding Information: Supported in part by the National Cancer Institute of the National Institutes of Health (K08CA234225). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.",

year = "2022",

month = apr,

doi = "10.1016/j.semradonc.2021.11.002",

language = "English",

volume = "32",

pages = "98--108",

journal = "Seminars in Radiation Oncology",

issn = "1053-4296",

publisher = "W. B. Saunders Company",

number = "2",

}

TY - JOUR

T1 - The Evolution of Geriatric Oncology and Geriatric Assessment over the Past Decade

AU - Outlaw, Darryl

AU - Abdallah, Maya

AU - Gil-Jr, Luiz A.

AU - Giri, Smith

AU - Hsu, Tina

AU - Krok-Schoen, Jessica L.

AU - Liposits, Gabor

AU - Madureira, Tânia

AU - Marinho, Joana

AU - Subbiah, Ishwaria M.

AU - Tuch, Gina

AU - Williams, Grant R.

N1 - Funding Information: Supported in part by the National Cancer Institute of the National Institutes of Health (K08CA234225). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

PY - 2022/4

Y1 - 2022/4

N2 - Cancer is predominantly a disease of aging, and older adults represent the majority of cancer diagnoses and deaths. Older adults with cancer differ significantly from younger patients, leading to important distinctions in cancer treatment planning and decision-making. As a consequence, the field of geriatric oncology has blossomed and evolved over recent decades, as the need to bring personalized cancer care to older adults has been increasingly recognized and a focus of study. The geriatric assessment (GA) has become the cornerstone of geriatric oncology research, and the past year has yielded promising results regarding the implementation of GA into routine cancer treatment decisions and outcomes for older adults. In this article, we provide an overview of the field of geriatric oncology and highlight recent breakthroughs with the use of GA in cancer care. Further work is needed to continue to provide personalized, evidence-based care for each older adult with cancer.

AB - Cancer is predominantly a disease of aging, and older adults represent the majority of cancer diagnoses and deaths. Older adults with cancer differ significantly from younger patients, leading to important distinctions in cancer treatment planning and decision-making. As a consequence, the field of geriatric oncology has blossomed and evolved over recent decades, as the need to bring personalized cancer care to older adults has been increasingly recognized and a focus of study. The geriatric assessment (GA) has become the cornerstone of geriatric oncology research, and the past year has yielded promising results regarding the implementation of GA into routine cancer treatment decisions and outcomes for older adults. In this article, we provide an overview of the field of geriatric oncology and highlight recent breakthroughs with the use of GA in cancer care. Further work is needed to continue to provide personalized, evidence-based care for each older adult with cancer.

U2 - 10.1016/j.semradonc.2021.11.002

DO - 10.1016/j.semradonc.2021.11.002

M3 - Journal article

C2 - 35307123

AN - SCOPUS:85121120431

SN - 1053-4296

VL - 32

SP - 98

EP - 108

JO - Seminars in Radiation Oncology

JF - Seminars in Radiation Oncology

IS - 2

ER -

The Evolution of Geriatric Oncology and Geriatric Assessment over the Past Decade

Abstract

Bibliografisk note

Finansiering

Dokumenter og links

SDU link

Fingeraftryk

Citationsformater